Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 11:57 PM
Study NCT ID:
NCT04532294
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2020-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-27
First Submit QC Date:
None
Study First Post Date:
2020-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-19
Results First Submit QC Date:
None
Results First Post Date:
2022-01-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL